Hepatotoxicity Development During Antiretroviral Therapy Containing Protease Inhibitors in Patients With HIV

Autor: Aceti, A, Pasquazzi, C, Zechini, B, De Bac, C, Liverhaart, Group, Cargnel, A, Giorgi, R, Carosi, G, Torti, C, Chiodo, F, Giuliani, R, Concia, Ercole, Cainelli, F, Ghinelli, F, Roda, R, Mazzotta, F, Pierotti, L, Milazzo, F, Fagion, I, Minoli, L, Rizzi, L, Mura, Ms, Sotgiu, G, Ortona, L, Di Gianbenedetto, S, Pastore, G, Cavaliere, R, Piazza, M, Maddaloni, L, Sagnelli, E, Nacca, C, Scalise, G, Del Prete MS, Vullo, V, Santopadre, P.

Publikováno v: Scopus-Elsevier

To evaluate the occurrence of hepatotoxicity in patients during antiretroviral therapy (ART) that contains protease inhibitors and the role of hepatitis viruses in its development, we performed a retrospective study including 1325 HIV-infected patien

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::343987ddc569bb446c01efd45bc01f47
https://doi.org/10.1097/00042560-200201010-00005

P.412 Impact of occult HBV infection in HIV patients naive for anti-retroviral therapy

Autor: Filippini P, COPPOLA, Nicola, Pisapia R, Scolastico C, Marrocco C, Zaccariello A, Nacca C, De Stefano G, Ferraro T, De Stefano C, Sagnelli E., SAGNELLI, Caterina

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3977::cc089f15287a523fe0875a9b3cfaef64
http://hdl.handle.net/11591/222794

Tuberculosis in HIV-infected persons in the context of wide availability of highly active antiretroviral therapy

Autor: Girardi, E., Antonucci, G., Vanacore, P., Palmieri, F., Matteelli, A., Iemoli, E., Carradori, S., Salassa, B., Pasticci, M. B., Raviglione, M. C., Ippolito, G., Babudieri, S., Bassetti, M., Rosso, R., Carbonara, S., Celesia, B. M., Chirianni, A., Di Perri, G., Fabietti, P., Gabutti, A., Guadagnino, V., Manfrin, V., Zacchini, F., Burzacchini, F., Giacometti, A., Tassara, A., Traverso, A., Giorni, P., Gobbi, M., Mariani, R., Di Gennaro, G., Panella, L., Losappio, R., Beltrami, C., Costigliola, P., Fasulo, G., Moling, O., Bertelli, D., Tedoldi, S., Potenza, D., Manconi, P. E., Zichichi, S., Nacca, C., Fatuzzo, F., La Rosa, R., Galvagna, S., Grosso, C., Vecchiet, J., Longoni, E., Guaglianone, L., Pan, A., Pellicano, S., Raineri, G., Ferrara, S., Anzalone, E., Gallo, A., Cataldini, S., Dodi, F., Petronio, A., Salone, G., De Luca Andrioli, E. P., De Checchi, G., Villa, M., Pardelli, R., Tardio, A., Urbani, C., Gattuso, G., Matini, L., Casciano, G., Loschiavo, F., Errante, I., Giani, G., Meraviglia, P., Molteni, C., Guaraldi, G., Foresti, S., Abbrescia, N., Izzo, C., Filippini, P., Noce, S., Dalle Nogare, E. R., Farinella, E., Sacchi, P., Scudeller, L., Petrelli, E., Alterio, L., Paolillo, F., Savalli, E., Doria, R., Catalani, M., Brizzi, M., Storaci, N., Natalini Raponi, G. P., Martelli, L. T., Grisetti, S., Lanini, S., Santopadre, P.

Publikováno v: The European respiratory journal. 24(1)

Highly active antiretroviral therapy (HAART) greatly reduces the risk of developing tuberculosis for HIV-infected persons. Nonetheless, HIV-associated tuberculosis continues to occur in countries where HAART is widely used. To identify the characteri

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3d646ecdb001e14575c8e3973decf7b
https://pubmed.ncbi.nlm.nih.gov/15293599

Open, Randomized, Multicentre Italian Trial on Peg-Ifn plus Ribavirin versus Peg-Ifn Monotherapy for Chronic Hepatitis C in HIV-Coinfected Patients on Haart

Autor: Cargnel, Antonietta, Angeli, Elena, Mainini, Annalisa, Gubertini, Guido, Giorgi, Riccardo, Schiavini, Monica, Duca, Piergiorgio, Scalise, G, Cesare, S Di, Chiodo, F, Verucchi, G, Farci, P, Serra, G, Sagnelli, E, Nacca, C, Ferraro, T, Scerbo, A, Santoro, D, Pusterla, L, Viganò, P, Magnani, C, Ghinelli, F, Sighinolfi, L, Vigevani, G, Pastecchia, C, Moroni, M, Milazzo, L, Esposito, R, Borghi, V, Piccinino, F, Filippini, P, Cadrobbi, P, Sattin, A, Ferrari, C, Antoni, A Degli, Stagni, G, Francisci, D, Petrelli, E, Alberici, F, Sacchini, D, Zauli, T, Donà, D De, Arlotti, M, Mori, F, Marranconi, F, Caramello, P, Lipani, F, Soranzo, ML, Macor, A, Vaglia, A, Rossi, MC, Grossi, P, Tambini, R, De Lalla, F, Tositti, G

Publikováno v: Antiviral Therapy; February 2005, Vol. 10 Issue: 2 p309-317, 9p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.